• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Country Philippines

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-02-01-2014
Volume 0
Issue 0

Connecting the Dots The inclusion of healthcare as a priority on the presidential agenda has led to knock-on consequences that are being felt across the healthcare value chain in the Philippines. Universal healthcare coverage (UHC) has been cemented, which has led to a shift from branded medicines to generics, leading many players to a strategic repositioning. The most successful players have been those who focused on a strategy that was inclusive of all stakeholders and aligned with the presidential agenda of affordable and accessible healthcare.

External Link - article-834930.doc

Articles in this issue
i12_t-834930-1408525551008.gif
Country Philippines
line-834478-1408526138664.gif
Will Europe's Regulatory Watchdog Come Of Age In 2014?
Managed Markets: Positioning Your Product For Success with Pull Through Strategies
Managed Markets: Positioning Your Product For Success with Pull Through Strategies
line-834481-1408526130758.gif
Russian Innovation: A Higher Mark
The Active Patient: Faces Of Change
The Active Patient: Faces Of Change
line-834480-1408526133448.gif
Social Media: Have We Reached The Tipping Point?
Takeda's Oncology Taskmaster
Takeda's Oncology Taskmaster
Product Positioning 2.0
Product Positioning 2.0
line-834479-1408526136002.gif
A Spark From GSK
Related Content
Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Mike Ryan

Global Expansion: Q&A with Mike Ryan

Mike Hollan
November 13th 2024
Article

EVERSANA's Ryan discusses the company’s recent expansion into new markets in Europe.

Vikram Anand

The Global Stage: Q&A with EVERSANA’s Vikram Anand

Mike Hollan
October 29th 2024
Article

The president of compliance services discusses the company’s recent expansion into new markets.

IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment

IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment

Don Tracy, Associate Editor
August 20th 2024
Article

In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.

Asia Embracing New Technologies for Better Healthcare

Asia Embracing New Technologies for Better Healthcare

Bruce Liu
August 13th 2024
Article

The region is moving to the forefront in integrating therapeutic innovation.